Page last updated: 2024-12-05

methylpentynol carbamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID9333
CHEMBL ID453247
SCHEMBL ID1171403
MeSH IDM0062357

Synonyms (44)

Synonym
psicosedina
meparfynol carbamate
carbamic acid, 1-ethyl-1-methyl-2-propynyl ester
oblivon n
pentin c
n oblivon
usaf el-108
1-ethyl-1-methylprop-2-ynyl carbamate
einecs 206-125-9
anansiol
methylpentynol carbamate
formarin
3-carbamoyloxy-3-methyl-4-pentyne
2-ethynyl-2-butyl carbamate
carbamic acid, 2-ethynyl-2-butyl ester
olosed
ovetten
1-ethyl-1-methyl-2-propynyl carbamate
vereden
3-methyl-3-carbamyloxy-1-pentyne
methylparafynol carbamate
1-pentyn-3-ol, 3-methyl-, carbamate
3-methyl-3-(carbamyloxy)-4-pentyne
3-methyl-1-pentyn-3-ol carbamate
mepentamate
carbamate de methylpentinol [french]
calminol
brn 1762311
placidal
3-methylpent-1-yn-3-yl carbamate
CHEMBL453247
unii-z7lgx24o53
z7lgx24o53 ,
carbamate de methylpentinol
302-66-9
AKOS006239577
meparfynol carbamate [mi]
(+/-)-3-methyl-1-propyn-3-ol carbamate
methylpentynol carbamate [who-dd]
SCHEMBL1171403
oblivon carbamate
GXCDLJXPZVCHBX-UHFFFAOYSA-N
Q27295118
DTXSID40871630
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID409956Inhibition of mouse brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (94.44)18.7374
1990's0 (0.00)18.2507
2000's1 (5.56)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]